The joint and individual correlations of CVD/T2D and BMI with cancer risk.
Vertex reports net profits of $2.69bn in Q1 2024 – Pharmaceutical Technology
Vertex’s Casgevy is the first CRISPR gene therapy on the market for the treatment of sickle cell anaemia. The company has launched the therapy across